National Systemic Anti-Cancer Therapy (SACT) consent forms – forms for HPB and prostate cancers published

Regimen-specific consent forms for the following tumour groups have been published on the Cancer Research UK website:
• Hepato Pancreato Biliary (HPB) cancers – 10 forms
• Urology-Prostate cancers – 4 forms
Please visit www.cruk.org/sact_consent to view and download the forms. Other forms, national guidance on consent for SACT, and further information is also available via www.cruk.org/sact_consent.
Please do not hesitate to contact Victoria Fashina (Oncology Pharmacist – CRUK information lead, Guy’s and St. Thomas’ NHS Foundation Trust) if you have any queries: [email protected]
Victoria Fashina

Latest News

By BOPA Research committee on 15th January 2026

Allied health and lifestyle support provision research survey

Dear members, Sheffield Hallam University’s Advanced Wellbeing Research Centre (AWRC) are working on behalf of Pfizer to identify the type of information, support and services offered to people living with metastatic…

Read article
By BOPA E&T Subcommittee on 15th January 2026

BOPA Introduction to Cancer Course, Scotland, March 2026 – LIMITED spaces available don’t miss out!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA E&T Subcommittee on 13th January 2026

Cancer Advanced and Consultant Pharmacist credentialing support series

As we head into 2026, BOPA is really pleased to share that the credentialing webinar support series from BOPA will continue in 2026. Through ongoing membership feedback, we’ve clearly identified…

Read article
By BOPA Research Committee on 26th December 2025

Optimising Medication in Older Adults Receiving Systemic Anticancer Therapies (SACT) – Research Study

We are inviting pharmacy professionals working in UK cancer services to take part in our study. What this research is about? To explore how pharmacy teams optimise medication for older…

Read article